Cargando…
Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines – Multi-country assessment
BACKGROUND: In 2010, a safety signal was detected for narcolepsy following vaccination with Pandemrix, an AS03-adjuvanted monovalent pandemic H1N1 influenza (pH1N1) vaccine. To further assess a possible association and inform policy on future use of adjuvants, we conducted a multi-country study of n...
Ejemplares similares
-
Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study
por: Dodd, Caitlin N., et al.
Publicado: (2018) -
No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
por: Lamb, Favelle, et al.
Publicado: (2016) -
Parental acceptance and knowledge of varicella vaccination in relation to socioeconomics in Sweden: A cross-sectional study
por: Arnheim-Dahlström, Lisen, et al.
Publicado: (2021) -
Exploring the clinical features of narcolepsy type 1 versus narcolepsy type 2 from European Narcolepsy Network database with machine learning
por: Zhang, Zhongxing, et al.
Publicado: (2018) -
Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe
por: Dieleman, Jeanne, et al.
Publicado: (2011)